Erasca Ownership | Who Owns Erasca?
Erasca Ownership Summary
Erasca is owned by 105.11% institutional investors, 5.94% insiders. Frazier life sciences management is the largest institutional shareholder, holding 8.21% of ERAS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.95% of its assets in Erasca shares.
ERAS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Erasca | 105.11% | 5.94% | -11.05% |
| Sector | Healthcare Stocks | 129.40% | 12.08% | -41.48% |
| Industry | Biotech Stocks | 181.71% | 11.69% | -93.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 24.98M | 8.21% | $457.55M |
| Blackrock funding, inc. /de | 23.74M | 7.62% | $347.97M |
| Blackrock | 10.61M | 7.02% | $25.04M |
| T. rowe price investment management | 21.19M | 6.96% | $388.13M |
| Rtw investments, lp | 17.95M | 5.90% | $328.78M |
| Vr adviser | 17.89M | 5.88% | $327.78M |
| Vanguard group | 12.81M | 4.52% | $47.66M |
| Vanguard capital management | 13.91M | 4.47% | $203.86M |
| State street | 13.82M | 4.44% | $202.63M |
| Artal group | 9.63M | 4.42% | $22.73M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Arch venture management | 7.09M | 11.81% | $129.92M |
| Frazier life sciences management | 24.98M | 9.96% | $457.55M |
| Vr adviser | 17.89M | 9.94% | $327.78M |
| Logos global management lp | 12.15M | 9.58% | $222.59M |
| Vivo capital | 4.02M | 6.49% | $58.94M |
| Cormorant asset management, lp | 6.00M | 5.63% | $109.92M |
| Kvp capital advisors, lp | 455.00K | 5.37% | $6.67M |
| Stempoint capital lp | 1.57M | 4.94% | $28.69M |
| Siren | 13.20M | 4.57% | $193.48M |
| Acuta capital partners | 265.20K | 3.39% | $4.86M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | 9.36M | 0.02% | 8.66M |
| Vanguard portfolio management | 8.45M | 0.01% | 6.06M |
| Artal group | 9.63M | 0.58% | 4.91M |
| Price t rowe associates inc /md/ | 6.27M | 0.01% | 4.46M |
| Janus henderson group | 3.71M | 0.03% | 3.71M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -6.17M |
| Balyasny asset management | 658.17K | 0.01% | -4.49M |
| 5am venture management | - | - | -3.49M |
| Suvretta capital management | - | - | -3.43M |
| Commodore capital lp | - | - | -3.17M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Janus henderson group | 3.71M | 0.03% | 3.71M | $59.99M |
| Samlyn capital | 2.26M | 0.67% | 2.26M | $41.35M |
| Evergreen quality fund gp | 1.38M | 0.41% | 1.38M | $25.20M |
| Qube research | 1.25M | 0.01% | 1.25M | $18.38M |
| Caption management | 1.04M | 0.09% | 1.04M | $19.08M |
Sold Out
| Holder | Change |
|---|---|
| Clearstead advisors | -2.00 |
| Nelson, van denburg & campbell wealth management group | -18.00 |
| Mai capital management | -23.00 |
| National bank of canada /fi/ | -46.00 |
| Covestor | -73.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 299 | 9.12% | 327,242,697 | 15.92% | 105 | 1.28% | 185 | 11.45% | 65 | -18.75% |
| Jun 30, 2026 | 272 | 16.24% | 282,128,685 | 3.17% | 92 | 1.00% | 166 | -5.68% | 77 | 102.63% |
| Mar 31, 2026 | 228 | 44.30% | 270,198,449 | 23.22% | 95 | 1.59% | 172 | 126.32% | 38 | -19.15% |
| Dec 31, 2025 | 49 | -66.21% | 24,840,571 | -88.44% | 8 | 0.15% | 24 | -60.66% | 12 | -70.73% |
| Sep 30, 2025 | 44 | -67.88% | 17,749,176 | -91.74% | 6 | 0.11% | 18 | -78.05% | 15 | -55.88% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 8.39M | 2.95% | -5.64K |
| Vanguard MStar Total Stk Mkt Idx Invest | 10.14M | 2.90% | 336.38K |
| State Street® SPDR® S&P® Biotech ETF | 8.99M | 2.57% | 234.40K |
| Vanguard Morn Total Stk Mkt Idx Investor | 8.39M | 2.42% | -5.64K |
| American Funds SMALLCAP World A | 6.89M | 1.97% | 6.20M |
| iShares Russell 2000 ETF | 5.60M | 1.60% | - |
| T. Rowe Price US Small-Cap Core Equity | 3.28M | 1.16% | 737.06K |
| T. Rowe Price U.S. SC Value Eq Tr-Z | 2.91M | 1.03% | 147.12K |
| Vanguard Small Cap Index | 3.55M | 1.01% | 3.44M |
| Vanguard Institutional Extnd Mkt Idx Tr | 3.12M | 1.00% | 369.36K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 01, 2026 | Garner Ebun | Chief Legal Officer | Sell | $1.31M |
| Mar 04, 2026 | Morris Shannon | Chief Medical Officer | Sell | $300.76K |
| Jan 07, 2026 | Garner Ebun | General Counsel & Corp. Sec. | Sell | $670.81K |
| May 21, 2024 | Casdin Alexander W. | - | Buy | $181.92K |
| Dec 06, 2023 | Start Valerie Denise Harding | - | Buy | $18.48K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2026 Q2 | - | 1 |
| 2026 Q1 | - | 2 |
| 2025 Q4 | - | - |
| 2025 Q2 | - | - |
ERAS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools